Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited

BACKGROUND: Intravenous recombinant tissue plasminogen activator (rtPA) is approved in Europe for use in patients with acute ischaemic stroke who meet strictly defined criteria. IST-3 sought to improve the external validity and precision of the estimates of the overall treatment effects (efficacy an...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Sandercock, Peter, Lindley, Richard, Wardlaw, Joanna, Dennis, Martin, Innes, Karen, Cohen, Geoff, Whiteley, Will, Perry, David, Soosay, Vera, Buchanan, David, Venables, Graham, Czlonkowska, Anna, Kobayashi, Adam, Berge, Eivind, Slot, Karsten Bruins, Murray, Veronica, Peeters, Andre, Hankey, Graeme J, Matz, Karl, Brainin, Michael, Ricci, Stefano, Cantisani, Teresa A, Gubitz, Gordon, Phillips, Stephen J, Antonio, Arauz, Correia, Manuel, Lyrer, Phillippe, Kane, Ingrid, Lundstrom, Erik
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2011
Ämnen:
Update
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3286387/
https://ncbi.nlm.nih.gov/pubmed/22129158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-12-252
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk